Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
Pharmacology & Therapeutics|June 23, 2018
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunitiesFilipa Lynce, Ayesha N Shajahan-Haq, Sandra M Swain
Current Molecular Pharmacology|January 11, 2013
Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS metastases: the Road less TravelledIrina Veytsman, Jeanny B Aragon-Ching, Sandra M Swain
Journal of the National Cancer Institute. Monographs|October 20, 2010
The impact of systemic therapy following ductal carcinoma in situJennifer Eng-Wong, Joseph P Costantino, Sandra M Swain
Clinical Breast Cancer|February 3, 2004
Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancerEleftherios P Mamounas, Charles E Geyer, Sandra M Swain
Expert Opinion on Emerging Drugs|August 31, 2006
Emerging drugs to replace current leaders in first-line therapy for breast cancerMichael C Cox, Tu D Dan, Sandra M Swain
International Journal of Oncology|March 15, 2011
p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancerSherry X Yang, Seth M Steinberg, Dat Nguyen, et al.
Breast Cancer Research and Treatment|September 14, 2017
Take care of your neighborhoodElmer E Huerta, Patricia Weeks-Coulthurst, Courtney Williams, et al.
Clinical Breast Cancer|October 4, 2016
HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based RegimensJennifer J Gao, Ming Tan, Paula R Pohlmann, et al.
The Oncologist|May 29, 2012
A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trialsDeliya R Banda, Alexander V Libin, Hong Wang, et al.
NPJ Breast Cancer|September 30, 2024
Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA studyIlana Schlam, D Max Smith, Cody Peer, et al.
Pageof 19